Teva, Alvotech get FDA nod for Johnson & Johnson biosimilar
Source: SeekingAlpha
2025-05-05 09:27:36 ET
More on Alvotech, Teva Pharmaceutical, etc.
- Alvotech: Potential Victim Of Pharma Tariff Threats (Rating Downgrade)
- Alvotech (ALVO) Q4 2024 Earnings Call Transcript
- Alvotech 2024 Q4 - Results - Earnings Call Presentation
- Earnings week ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and more
- Teva, Samsung Bioepis launch biosimilar against AstraZeneca’s Soliris
Read the full article on Seeking Alpha
For further details see:
Teva, Alvotech get FDA nod for Johnson & Johnson biosimilar
Alvotech
NASDAQ: ALVO
ALVO Trading
-6.23% G/L:
$3.01 Last:
679,105 Volume:
$3.23 Open:
ALVO Latest News
May 11, 2026 04:30:00 am
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
